WASHINGTON, D.C., July 1, 2022 – The Securing America’s Medicines and Supply (SAMS) coalition — a multi-industry coalition of companies with the mission to strengthen the security of the medical supply chain in the United States — commends the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies for supporting domestic medical manufacturing in its FY23 appropriations package.
The legislative package correctly identifies the threat of the United States’ reliance on medical products produced overseas and offers an effective, market-driven solution that backs American companies. The Committee’s recommendation that the Centers for Medicare & Medicaid Services (CMS) develop a program to identify innovative payment policies for domestic manufacturers of generic and biosimilar medications will allow American firms to reinforce the domestic medical supply chain amidst global upheaval. The proposed reforms to the CMS’ payment plans will also protect American jobs and foster innovation amongst pharmaceutical companies in the United States.
SAMS endorses the Committee’s commitment to protecting the American medical supply chain by supporting domestic manufacturing and hopes that Congress will consider additional legislation, such as the American Made Pharmaceuticals Act, to ensure that the United States is well-equipped to address any public health emergency.
About Securing America’s Medicines and Supply
Securing America’s Medicines and Supply (SAMS) is a multi-industry coalition of companies with the mission to strengthen the security of the medical supply chain in the United States. SAMS seeks to drive implementation of legislation and regulation to reward and foster U.S.-made manufacturing of important pharmaceutical products, devices, and supplies. SAMS supports U.S. patients, domestic healthcare security, and U.S. jobs.